skip to Global Navigation Bar
skip to main content
HOME
CONTACT US
SITEMAP
KOREAN
Global Business
Introduction
Strategy
Manufacturing
Contact Us
R&D
Introduction
Global R&D Centers
R&D Organization
Pipeline
CDMO
Introduction
Manufacturing Sites
Business Model
Service Range
Products
Global Brand
Products Search
In-License
Introduction
Strategy
No.1 Position
Core-Competency
Licensed Products
Partnership
Investors
Management information
Financial information
Stock condition
IR information
About Us
Company Profile
CEO Message
Recruitment
Press Release
Introduction
Global R&D Centers
Global R&D Centers
Overseas
R&D Organization
Pipeline
Home > R&D > Introducing Labs >
Global R&D Centers
Life Science Research Institute
(Yongin, South Korea)
01.
New Chemical Entity (NCE)
- Therapeutic areas: Autoimmune diseases, Metabolic diseases
- In-vitro/in-vivo evaluation for autoimmune drugs
02.
Incrementally Modified Drugs
- Sustained-release technologies including Depot
- Differentiated fixed-dose combination technology
03.
Synthesis technology for high-level APIs such as peptides
Daewoong Bio Center
(Yongin, South Korea, Oct. 2016)
01.
Recombinant products including therapeutic antibodies
- Bio-betters using long-acting technology, Growth factors
02.
Stem cell research for enhancement of efficacy
- Innovative stem cell line establishment
- Stem cell bioprocess
- Discovery of new indications
03.
Development of Botulinum toxin drugs - Next generation toxin
Liaoning Research Center
(China, Oct 2014)
01.
Development of generics for China market entry
02.
Formulation R&D
- New oral solutions, Suspension products, Sustained-release drugs
03.
Academic collaboration
(ex.Shenyang Pharmaceutical Univ.)
Hyderabad Research Center
(India, Jan 2009)
01.
Development of first generics
02.
Development of global generics for EU/US market entry
- Sustained-release drugs, Formulation change
Jakarta Research Center
(Indonesia, Dec 2016)
01.
Development of biotechnology-driven products
- EPO, EGF, hGH
- Extensions of indication through clinical studies
02.
Focus on reverse innovation and open collaboration
(ex. Univ. of Indonesia)